Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IWG Plc Director's Dealing 2018

Dec 14, 2018

6276_dirs_2018-12-14_290f012d-d746-4044-8820-5bc6deb9b7a9.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5160K

IWG PLC

14 December 2018

IWG plc (the "Company") 

Transaction notification 

1. 

Details of PDMR / person closely associated with them ("PCA") 

a) 

Name 

Estorn Limited 

b) 

Position / status  

Person closely associated with Mark Dixon, CEO (100% owned company)

c) 

Initial notification / amemdment 

Initial notification

2. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

a)  

Description of the financial instrument  

Ordinary shares of IWG plc 

b) 

Nature of the transaction 

Purchase of ordinary shares

c)  

Price(s) and volume(s) 

Price(s) GBP Volume(s)
2.030

2.030

2.029

2.030

2.030

2.030

2.030

2.030
2500

4895

287550

192452

1182

1

555

1436

d) 

Aggregated information  

·      Aggregated volume  

·      Price  

Total number of shares 490,571

Weighted average price GBP 2.0292

Of which

Aquis Exchange

Volume 2500

Weighted average price GBP 2.03

BATP

Volume 4895

Weighted average price GBP 2.03

LISX

Volume 480002

Weighted average price GBP 2.03

London Stock Exchange

Volume 3174

Weighted average price GBP 2.03

Date of the transaction 

2018-12-13 GMT

f) 

Place of the transaction  

Exchanges: Aquis, BATP, LISX, London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHFFESULFASEEE